ms SALLY GUTHRIE — Lobbyist Profile | Poliscope

ms SALLY GUTHRIE

Filings

Clients

Firms

Years active

2022–2026

Associated filing income

—

How to read the money

Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.

Clients represented

Client	Filings	Years
BECTON DICKINSON AND COMPANY	20	2022–2026

Lobbying firms

Firm	Filings	Years
BECTON, DICKINSON AND COMPANY	20	2022–2026

Bills explicitly cited in this lobbyist’s assigned issues (20)

No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.

H.R. 2369

VALID Act of 2023

Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY

Open original LDA filing ↗

Cited source text

H.R. 2369

VALID Act of 2023

Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY

Open original LDA filing ↗

Cited source text

Original LDA source filings (20)

Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.

BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY

2026 · first_quarter · 1A

Firm income: —Client expense: $780,000Open original LDA filing ↗

Assigned issues and filing targets (5 issues)

TRD

Trade (domestic/foreign)

Issues related to medical device supply chain Issues related to international trade

MMM

Medicare/Medicaid

Issues related to reimbursement Issues related to CY2026 Home Health and DMEPOS PPS proposed rule and ANPRM on PPE and essential medicines

HCR

Source: Senate LDA

Show 16 more cited filings

H.R. 4261

ARC Act of 2023

Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY

Open original LDA filing ↗

Cited source text

H.R. 2369

VALID Act of 2023

Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY

Open original LDA filing ↗

Cited source text

H.R. 2369

VALID Act of 2023

Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY

Open original LDA filing ↗

Cited source text

H.R. 2369

VALID Act of 2023

Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY

Open original LDA filing ↗

Cited source text

H.R. 2369

VALID Act of 2023

Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY

Open original LDA filing ↗

Cited source text

H.R. 2461

Triple A Study Act

Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY

Open original LDA filing ↗

Cited source text

H.R. 2631

ARC Act of 2021

Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY

Open original LDA filing ↗

Cited source text

H.R. 4128

VALID Act of 2021

Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY

Open original LDA filing ↗

Cited source text

H.R. 4128

VALID Act of 2021

Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY

Open original LDA filing ↗

Cited source text

H.R. 4128

VALID Act of 2021

Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY

Open original LDA filing ↗

Cited source text

H.R. 4128

VALID Act of 2021

Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY

Open original LDA filing ↗

Cited source text

S. 1089

To amend the Families First Coronavirus Response Act to extend child nutrition waiver authority, and for other purposes.

Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY

Open original LDA filing ↗

Cited source text

S. 2209

VALID Act of 2021

Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY

Open original LDA filing ↗

Cited source text

S. 2209

VALID Act of 2021

Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY

Open original LDA filing ↗

Cited source text

S. 2209

VALID Act of 2021

Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY

Open original LDA filing ↗

Cited source text

S. 2290

Data Broker List Act of 2021

Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY

Open original LDA filing ↗

Cited source text

Show 16 more original filings

BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY

2025 · first_quarter · 1A

Firm income: —Client expense: $1,438,000Open original LDA filing ↗

Assigned issues and filing targets (4 issues)

HCR

Health Issues

Issues related to medical technology regulation Issues related to medical device supply chains and supply chain resiliency Issues related to medical device sterilization

TAX

Taxation/Internal Revenue Code

Issues related to corporate taxation Tax incentives for domestic manufacturing

BUD

Budget/Appropriations

Issues related to medical device supply chains and supply chain resiliency Issues related to medical research funding Issues related to medical device sterilization

TRD

Trade (domestic/foreign)

Issues related to medical device supply chain

Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY

2025 · second_quarter · 2A

Firm income: —Client expense: $557,000Open original LDA filing ↗

Assigned issues and filing targets (4 issues)

HCR

Health Issues

Issues related to medical technology regulation Issues related to medical device supply chains and supply chain resiliency Issues related to medical device sterilization Issues related to preventative screenings Issues related to maternal health

TAX

Taxation/Internal Revenue Code

Issues related to corporate taxation Tax incentives for domestic manufacturing

BUD

Budget/Appropriations

Issues related to medical device supply chains and supply chain resiliency Issues related to medical research funding Issues related to medical device sterilization

BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY

2025 · second_quarter · Q2

Firm income: —Client expense: $557,000Open original LDA filing ↗

Assigned issues and filing targets (4 issues)

HCR

Health Issues

TAX

Taxation/Internal Revenue Code

Issues related to corporate taxation Tax incentives for domestic manufacturing

BUD

Budget/Appropriations

Issues related to medical device supply chains and supply chain resiliency Issues related to medical research funding Issues related to medical device sterilization

BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY

2025 · first_quarter · Q1

Firm income: —Client expense: $1,303,000Open original LDA filing ↗

Assigned issues and filing targets (4 issues)

HCR

Health Issues

Issues related to medical technology regulation Issues related to medical device supply chains and supply chain resiliency Issues related to medical device sterilization

TAX

Taxation/Internal Revenue Code

Issues related to corporate taxation Tax incentives for domestic manufacturing

BUD

Budget/Appropriations

Issues related to medical device supply chains and supply chain resiliency Issues related to medical research funding Issues related to medical device sterilization

BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY

2024 · fourth_quarter · Q4

Firm income: —Client expense: $485,000Open original LDA filing ↗

Assigned issues and filing targets (4 issues)

BUD

Budget/Appropriations

Issues related to medical device sterilization Issues related to medical device supply chains and supply chain resiliency Issues related to medical research funding Issues related to the National Defense Authorization Act

TAX

Taxation/Internal Revenue Code

Issues related to corporate taxation Tax incentives for domestic manufacturing

TRD

Trade (domestic/foreign)

Issues related to medical device supply chain

BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY

2024 · third_quarter · Q3

Firm income: —Client expense: $400,000Open original LDA filing ↗

Assigned issues and filing targets (4 issues)

HCR

Health Issues

Issues related to medical device sterilization Issues related to medical technology regulation Issues related to pandemic preparedness and coronavirus response Issues related to medical device supply chains and supply chain resiliency Issues related to clinical trials at the National Cancer Institute U.S. Preventive Services Task Force (USPSTF) Guidelines H.R.3633, PREVENT HPV Cancers Act of 2023

BUD

Budget/Appropriations

TRD

Trade (domestic/foreign)

BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY

2024 · second_quarter · Q2

Firm income: —Client expense: $427,000Open original LDA filing ↗

Assigned issues and filing targets (4 issues)

BUD

Budget/Appropriations

Issues related to medical device sterilization Issues related to medical device supply chains and supply chain resiliency Issues related to medical research funding

TRD

Trade (domestic/foreign)

Issues related to medical device supply chain

TAX

Taxation/Internal Revenue Code

Issues related to corporate taxation Tax incentives for domestic manufacturing

HCR

BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY

2024 · first_quarter · Q1

Firm income: —Client expense: $872,000Open original LDA filing ↗

Assigned issues and filing targets (2 issues)

HCR

Health Issues

TAX

Taxation/Internal Revenue Code

Issues related to corporate taxation Tax incentives for domestic manufacturing

Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY

2023 · fourth_quarter · Q4

Firm income: —Client expense: $720,000Open original LDA filing ↗

Assigned issues and filing targets (2 issues)

HCR

Health Issues

TAX

Taxation/Internal Revenue Code

Issues related to corporate taxation Tax incentives for domestic manufacturing

Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY

2023 · third_quarter · Q3

Firm income: —Client expense: $310,000Open original LDA filing ↗

Assigned issues and filing targets (2 issues)

HCR

Health Issues

TAX

Taxation/Internal Revenue Code

Issues related to corporate taxation Tax incentives for domestic manufacturing

Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY

2023 · second_quarter · Q2

Firm income: —Client expense: $310,000Open original LDA filing ↗

Assigned issues and filing targets (2 issues)

TAX

Taxation/Internal Revenue Code

Issues related to corporate taxation Tax incentives for domestic manufacturing

HCR

Health Issues

Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY

2023 · first_quarter · Q1

Firm income: —Client expense: $570,000Open original LDA filing ↗

Assigned issues and filing targets (2 issues)

TAX

Taxation/Internal Revenue Code

Issues related to corporate taxation Tax incentives for domestic manufacturing

HCR

Health Issues

Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY

2022 · fourth_quarter · Q4

Firm income: —Client expense: $480,000Open original LDA filing ↗

Assigned issues and filing targets (2 issues)

TAX

Taxation/Internal Revenue Code

Issues related to corporate taxation Tax incentives for domestic manufacturing

HCR

Health Issues

Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY

2022 · third_quarter · Q3

Firm income: —Client expense: $440,000Open original LDA filing ↗

Assigned issues and filing targets (2 issues)

TAX

Taxation/Internal Revenue Code

Issues related to corporate taxation Tax incentives for domestic manufacturing

HCR

Health Issues

Issues related to medical device sterilization Issues related to medical technology regulation Issues related to pandemic preparedness and coronavirus response Issues related to medical device supply chains and supply chain resiliency Issues related to community health centers H.R.4128, VALID Act of 2021 S.2209, VALID Act of 2021 Issues related to Hernia awareness Issues related to Oncology

Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY

2022 · second_quarter · Q2

Firm income: —Client expense: $500,000Open original LDA filing ↗

Assigned issues and filing targets (2 issues)

TAX

Taxation/Internal Revenue Code

Issues related to corporate taxation Tax incentives for domestic manufacturing

HCR

Health Issues

Issues related to medical device sterilization Issues related to medical technology regulation Issues related to pandemic preparedness and coronavirus response Issues related to medical device supply chains and supply chain resiliency Issues related to community health centers H.R.4128, VALID Act of 2021 S.2209, VALID Act of 2021 Issues related to Hernia awareness Issues related to Oncology

Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY

2022 · first_quarter · Q1

Firm income: —Client expense: $650,000Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

HCR

Health Issues

Issues related to medical device sterilization Issues related to medical technology regulation Issues related to pandemic preparedness and coronavirus response Issues related to medical device supply chains and supply chain resiliency Issues related to community health centers H.R.4128, VALID Act of 2021 S.2290, VALID Act of 2021 H.R.2461, Triple A Study Act S.1089, Triple A Study Act H.R.2631, Amputation Reduction and Compassion Act Issues related to chronic disease

Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE